Cyanotech Corp (CYAN) stock
CYANOTCMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
$0.70+0.00 (0.00%)
Close on Oct 19, 2026Market cap $5.11MP/E –Yield –
Cyanotech operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Cyanotech's operating income for the twelve months ending Sep 30, 2025 was -$1.06M. For fiscal 2025 it was -$2.51M. The highest annual figure on record is $2.90M in fiscal 2012.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | -$2.51M | – |
| FY2024 | Mar 31, 2024 | -$4.59M | – |
| FY2023 | Mar 31, 2023 | -$2.92M | -213.4% |
| FY2022 | Mar 31, 2022 | $2.57M | +2964.3% |
| FY2021 | Mar 31, 2021 | $84.00K | -92.0% |
| FY2020 | Mar 31, 2020 | $1.05M | – |
| FY2019 | Mar 31, 2019 | -$3.00M | -312.0% |
| FY2018 | Mar 31, 2018 | $1.41M | – |
| FY2017 | Mar 31, 2017 | -$682.00K | – |
| FY2016 | Mar 31, 2016 | -$785.00K | -343.8% |
| FY2015 | Mar 31, 2015 | $322.00K | – |
| FY2014 | Mar 31, 2014 | -$210.00K | -109.4% |
| FY2013 | Mar 31, 2013 | $2.23M | -23.4% |
| FY2012 | Mar 31, 2012 | $2.90M | +136.2% |
| FY2011 | Mar 31, 2011 | $1.23M | -18.1% |
| FY2010 | Mar 31, 2010 | $1.50M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $190.00K | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$753.00K | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$442.00K | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$50.00K | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$975.00K | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$1.04M | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$1.90M | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$848.00K | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$632.00K | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$1.21M | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$1.25M | -444.5% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$404.00K | -179.5% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$837.00K | -177.4% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$425.00K | -168.7% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $364.00K | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $508.00K | – |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $1.08M | +283.7% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $619.00K | +131.0% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -$25.00K | -111.0% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -$441.00K | -220.2% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $282.00K | -31.1% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $268.00K | +446.9% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $228.00K | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $367.00K | -25.9% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $409.00K | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $49.00K | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$1.32M | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $495.00K | -55.4% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | -$1.00M | -262.2% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$1.17M | -288.2% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$935.00K | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $1.11M | – |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $619.00K | +150.6% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $620.00K | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | -$146.00K | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | -$173.00K | -158.4% |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $247.00K | – |
| Q1 FY2017CQ2 2016 | Jun 30, 2016 | -$610.00K | – |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | -$747.00K | – |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | $296.00K | – |
See a number that looks wrong?